US OptionsDetailed Quotes

MDXG241115P10000

Watchlist

0.00
0.000.00%

15min DelayClose Oct 31 09:30 ET

0.00High0.00Low

MiMedx Stock Discussion

Stock Region

Mar 4 11:39

Investment Firm Raises Price Target For Major Biotech Company

Mizuho Boosts MiMedx Group's Price Target to $14, Continues Bullish Outlook.
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$
...

Moomoo AI

Mar 4 07:13

MIMEDX's Chair and CEO have expressed optimism about the new appointments, stating that Olson and Puhy will contribute to the company's strategic vision and provide valuable insights. Their skills and leadership records will elevate the Board.

Press Release: MIMEDX Announces Appointment of Two New Independent Directors

Moomoo AI

Jan 22 07:15

CFO Doug Rice asserts the new debt facility offers more flexibility for long-term strategic goals. The terms mirror the company's progress in enhancing its financial profile and reducing interest expense.

Press Release: MIMEDX Announces Improved Capital Structure With New Senior Secured Credit Facilities and Debt Refinancing

Moomoo AI

Dec 21, 2023 01:30

Analysts say that MiMedx's low projected revenue growth may contribute to its weak P/S ratio. Significant performance improvements would be needed for a potential P/S ratio rise. The low P/S ratio casts doubt on the company's potential despite its share price increase.

MiMedx Group, Inc. (NASDAQ:MDXG) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Moomoo AI

Dec 19, 2023 07:09

Carlson's experience could potentially elevate Spectral AI's position in the market. The potential impact of its breakthrough technology could present substantial opportunities for growth and value in the healthcare industry.

Press Release: Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

Moomoo AI

Dec 14, 2023 06:09

Despite a solid balance sheet, MiMedx Group only converted 45% of its EBIT to free cash flow last year. This is lower than expected and could complicate its debt management, despite an overall untroublesome net cash position.

Does MiMedx Group (NASDAQ:MDXG) Have A Healthy Balance Sheet?

Moomoo AI

Nov 22, 2023 05:13

Although MiMedx has potential, its debt level poses a financial risk that may slow its projected growth and profitability timeline. Forecasts may be too optimistic, with profitability later than anticipated. Investors are advised to due care examining valuation, management, and other performing stocks.

MiMedx Group, Inc. (NASDAQ:MDXG) On The Verge Of Breaking Even

Lane Lerche

Apr 24, 2023 01:11

$MiMedx (MDXG.US)$ @Mcsnacks H Tupack @Ripper1986 thoughts

Lane Lerche

Apr 24, 2023 01:10

$MiMedx (MDXG.US)$ i really like this im bullish here

Moomoo Breakfast US

Sep 13, 2022 07:42

Columns Today's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More

Gapping up
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...

No comment yet